Cargando…
Pyridoxamine improves survival and limits cardiac dysfunction after MI
Advanced glycation end products (AGEs) play a key role in the progression of heart failure. Whether treatments limiting AGEs formation would prevent adverse left ventricular remodeling after myocardial infarction (MI) remain unknown. We investigated whether pyridoxamine (PM) could limit adverse card...
Autores principales: | Deluyker, Dorien, Ferferieva, Vesselina, Driesen, Ronald B., Verboven, Maxim, Lambrichts, Ivo, Bito, Virginie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700185/ https://www.ncbi.nlm.nih.gov/pubmed/29167580 http://dx.doi.org/10.1038/s41598-017-16255-y |
Ejemplares similares
-
Combinational Therapy of Cardiac Atrial Appendage Stem Cells and Pyridoxamine: The Road to Cardiac Repair?
por: Evens, Lize, et al.
Publicado: (2021) -
Glycolaldehyde-modified proteins cause adverse functional and structural aortic remodeling leading to cardiac pressure overload
por: Haesen, Sibren, et al.
Publicado: (2020) -
High intensity training improves cardiac function in healthy rats
por: Verboven, Maxim, et al.
Publicado: (2019) -
Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats
por: D’Haese, Sarah, et al.
Publicado: (2023) -
Acute Exposure to Glycated Proteins Impaired in the Endothelium-Dependent Aortic Relaxation: A Matter of Oxidative Stress
por: D’Haese, Sarah, et al.
Publicado: (2022)